Back to Search
Start Over
Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene.
- Source :
-
Cell [Cell] 1990 Aug 10; Vol. 62 (3), pp. 435-45. - Publication Year :
- 1990
-
Abstract
- Expression of the polyoma virus middle T (mT) oncogene in vivo is associated with a profound subversion of normal vascular development, which results in the formation of endothelial tumors (hemangiomas). In an attempt to understand the molecular mechanisms responsible for this phenomenon, we have investigated, in an in vitro system, the morphogenetic properties of endothelial cells expressing this oncogene. mT-expressing endothelioma (End) cells grown within fibrin gels formed large hemangioma-like cystic structures. All End cell lines examined expressed high levels of fibrinolytic activity resulting from increased production of urokinase-type plasminogen activator and decreased production of plasminogen activator inhibitors. Neutralization of excess proteolytic activity by exogenously added serine protease inhibitors corrected the aberrant in vitro behavior of End cells and allowed the formation of capillary-like tubules. These results suggest that tightly controlled proteolytic activity is essential for vascular morphogenesis and that physiological protease inhibitors play an important regulatory role in angiogenesis.
- Subjects :
- Animals
Cell Line
Cells, Cultured
Endothelium, Vascular
Fibrin
Gene Expression
Hemangioma
Humans
Mice
Morphogenesis
Plasminogen Activators analysis
Plasminogen Inactivators analysis
RNA, Messenger genetics
Tumor Cells, Cultured cytology
Tumor Cells, Cultured ultrastructure
Antigens, Polyomavirus Transforming genetics
Fibrinolysis
Oncogenes
Plasminogen Activators genetics
Subjects
Details
- Language :
- English
- ISSN :
- 0092-8674
- Volume :
- 62
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Cell
- Publication Type :
- Academic Journal
- Accession number :
- 2379237
- Full Text :
- https://doi.org/10.1016/0092-8674(90)90009-4